Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant for CINV in Germ Cell Tumors Undergoing 5-Day Cisplatin
NCT00572572Phase 3Completed
- Sponsor
- Hoosier Cancer Research Network
- Start
- Dec 2007
- Primary completion
- Dec 2010
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aprepitant in chemotherapy-induced nausea and vomiting (CINV), sponsored by Hoosier Cancer Research Network. Started Dec 2007; status: completed.
02
Drugs
aprepitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00572572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00572572.